Gene is an executive vice president and global strategist based in London and currently serves as a rotating member of PIMCO’s investment committee. Prior to joining PIMCO in 2016, he was a partner ...

The companies will focus on advancing AXV-101, with which they hope to treat retinal dystrophy by targeting mutations in the BBS1 gene.